Bengaluru: Home healthcare services provider Portea Medical has expanded its services and forayed into specialised and critical home care. The suite of services also includes the end of life care for terminally ill patients.
Since the critical care market is pegged at $500 million, the company backed by investors such as Accel, Qualcomm Ventures, and Sabre Partners, would be further extending the services to chemotherapy-from-home and dialysis-from-home in the near future.
Latest posts by MD Team (see all)
- Recordati to seek Canadian approval for kidney disease drug Cystagon - April 17, 2019
- Wockhardt gets zero USFDA observations for Bioequivalence centre - April 16, 2019
- Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity - April 16, 2019